The Clinical Application of EEG-Signals Recurrence Analysis as a Measure of Functional Connectivity: Comparative Case Study of Patients with Various Neuropsychiatric Disorders

Background. An electroencephalogram (EEG) is a simple and widely used assessment tool that allows one to analyze the bioelectric activity of the brain. As a result, one can observe brain waves with different frequencies and amplitudes that correspond to the temporary synchronization of different parts of the brain. Synchronization patterns may be changed by almost any type of pathological conditions, such as psychiatric diseases and structural abnormalities of the brain tissue. In various neuropsychiatric disorders, the coordination of cortical activity may be decreased or enhanced as a result of neurobiological compensatory mechanisms. Methods. In this paper, we analyzed the EEG signals in resting-state condition, with reference to three patients with a similar set of psychopathological symptoms typical for the first psychotic episode, but with different functional and structural neural basis of the disease. Additionally, those patients were compared with a demographically matched healthy individual. We used the non-linear method of time series analysis based on the recurrences of states, to verify whether functional connectivity configurations assessed with recurrence method will qualitatively distinguish patients from a healthy subject, but also differentiate patients from each other. Results. Obtained results confirmed that the connectivity architecture mapped with the recurrence analysis substantially differentiated all participants from each other. An applied analysis additionally showed the specificity of cortical desynchronization and over-synchronization matched to the psychiatric or neurological basis of the disease. Despite this encouraging finding, group-oriented studies are needed to corroborate our qualitative results, based only on a series of clinical case studies.

The mGluR2/3 agonist LY379268 reverses NMDA receptor antagonist effects on cortical gamma oscillations and phase coherence, but not working memory impairments, in mice

BACKGROUND

Abnormalities in neural oscillations that occur in the gamma frequency range (30-80 Hz) may underlie cognitive deficits in schizophrenia. Both cognitive impairments and gamma oscillatory disturbances can be induced in healthy people and rodents by administration of N-methyl-D-aspartate receptor (NMDAr) antagonists.

AIMS

We studied relationships between cognitive impairment and gamma abnormalities following NMDAr antagonism, and attempted to reverse deficits with the metabotropic glutamate receptor type 2/3 (mGluR_2/3) agonist LY379268.

METHODS

C57/Bl6 mice were trained to perform the Trial-Unique Nonmatching to Location (TUNL) touchscreen test for working memory. They were then implanted with local field potential (LFP) recording electrodes in prefrontal cortex and dorsal hippocampus. Mice were administered either LY379268 (3 mg/kg) or vehicle followed by the NMDAr antagonist MK-801 (0.3 or 1 mg/kg) or vehicle prior to testing on the TUNL task, or recording LFPs during the presentation of an auditory stimulus.

RESULTS

MK-801 impaired working memory and increased perseveration, but these behaviours were not improved by LY379268 treatment. MK-81 increased the power of ongoing gamma and high gamma (130-180 Hz) oscillations in both brain regions and regional coherence between regions, and these signatures were augmented by LY379268. However, auditory-evoked gamma oscillation deficits caused by MK-801 were not affected by LY379268 pretreatment.

CONCLUSIONS

NMDA receptor antagonism impairs working memory in mice, but this is not reversed by stimulation of mGluR_2/3. Since elevations in ongoing gamma power and regional coherence caused by MK-801 were improved by LY379268, it appears unlikely that these specific oscillatory abnormalities underlie the working memory impairment caused by NMDAr antagonism.